Summary
Maps FDA and EMA regulatory requirements side-by-side, identifies alignment opportunities, and flags divergent expectations to support global development planning.
Detailed Description
The FDA/EMA Alignment Pack enables sponsors to develop harmonized global regulatory strategies by systematically comparing FDA and EMA requirements across clinical, nonclinical, and CMC domains. It draws on guidance documents from both agencies, ICH harmonization guidelines, and published analyses of regulatory divergence.
The pack performs a structured comparison of FDA and EMA expectations for your development program, identifying areas of alignment where a single dataset can satisfy both agencies and flagging areas of divergence requiring region-specific strategies. It maps parallel scientific advice opportunities and joint review mechanisms.
Deliverables include a regulatory alignment matrix, a divergence analysis with mitigation strategies, and a global development plan framework optimized for simultaneous FDA and EMA submissions.
Evidence Sources
| Source | Type | Description | Refresh |
|---|---|---|---|
| FDA Guidance Library | REGULATORY | Complete FDA guidance library across clinical, nonclinical, and CMC domains | Monthly |
| EMA Scientific Guidelines | REGULATORY | EMA scientific guidelines, reflection papers, and CHMP position statements | Monthly |
| ICH Harmonization Guidelines | REGULATORY | ICH guidelines representing harmonized standards across FDA, EMA, and other regulatory authorities | Quarterly |
Regulatory Mapping
The Common Technical Document
General Principles for Planning and Design of Multi-Regional Clinical Trials
Guideline on the Common Technical Document for the Registration of Medicinal Products
Agent Transparency
When you run this pack, your request is processed by a pipeline of specialized AI agents. Each agent operates with a defined confidence threshold and is auditable end-to-end.
Evidence Retriever
brew-retriever-v3
Queries curated sources for relevant evidence objects. Searches across regulatory databases, clinical registries, and scientific literature to surface the most pertinent references for the pack domain.
Domain Analyzer
brew-domain-analyst-v2
Applies domain-specific reasoning and regulatory mapping. Interprets evidence in the context of FDA, ICH, and EMA frameworks and tags each finding with the relevant guidance references.
Evidence Synthesizer
brew-synthesizer-v2
Synthesizes findings into structured output. Combines retrieved evidence and domain analysis into a cohesive narrative with quantitative summaries, comparative tables, and actionable recommendations.
Output Validator
brew-validator-v1
Validates citations, checks confidence thresholds, and ensures all referenced sources are accessible and correctly attributed. Flags any claims that fall below the confidence floor.
Sample Outputs
Regulatory Alignment Matrix
XLSXSide-by-side comparison of FDA and EMA requirements across all CTD modules
Divergence Analysis
PDFDetailed analysis of regulatory divergences with mitigation strategies and cost-benefit assessment
Global Development Plan Framework
PDFIntegrated global development plan optimized for simultaneous FDA/EMA submissions
Deliverables included
- FDA/EMA regulatory alignment matrix
- Divergence analysis with mitigation strategies
- Global development plan framework
- Parallel scientific advice strategy
- Regional labeling considerations analysis
Related Disease & Biomarker Mappings
| Therapeutic Area | Disease Family | Key Biomarkers | Relevance |
|---|---|---|---|
| Cross-Therapeutic | Regulatory Strategy | N/A — regulatory focus | Primary |
| Oncology | Accelerated Approval Programs | ORRDORctDNA response | Secondary |
Related Packs in Regulatory Strategy
FDA IND Strategy Pack
File your IND right the first time
Breakthrough/Fast Track Evidence Pack
Maximize your chances for expedited designation
Pre-Submission Meeting Prep Pack
Walk into every FDA meeting fully prepared
Global Regulatory Intelligence Pack
Track regulatory shifts across 40+ markets in real time
Version History
Current release — expanded evidence sources, improved citation accuracy, and added new regulatory cross-references.
Beta release — validated with domain SMEs. Added sample output previews and refined confidence scoring.
Initial draft — core evidence retrieval pipeline and output schema established.
Need a Custom Evidence Pack?
Our enterprise team can build bespoke evidence packs tailored to your therapeutic area, regulatory strategy, or internal decision framework. Custom packs include dedicated evidence source curation, domain-specific agent tuning, and priority SLA support.
Enterprise packs are available for organizations on the BrewBio Pro or Enterprise plan.